## Fetal Fibronectin (fFN) in Preterm Labor: Mechanism and Clinical Utility ### What Is Fetal Fibronectin? **Key Point:** Fetal fibronectin is a glycoprotein component of the extracellular matrix at the maternal-fetal interface. Its presence in cervicovaginal secretions indicates disruption of the choriodecidual interface and is associated with preterm labor. ### Clinical Utility of fFN Testing | Characteristic | Details | |---|---| | **Optimal gestational age window** | 22–34 weeks (most useful 24–34 weeks) | | **Specimen collection** | Cervicovaginal swab (before digital cervical exam) | | **Positive threshold** | ≥ 50 ng/mL | | **Negative predictive value** | 90–99% for delivery within 7 days (highly reassuring) | | **Positive predictive value** | 20–40% (not highly specific) | | **Clinical interpretation** | Negative = low risk; Positive = intermediate risk | ### Why fFN Positivity Does NOT Guarantee Imminent Delivery **High-Yield:** A positive fFN test indicates increased risk of preterm delivery but does NOT predict imminent delivery within 24 hours in all cases. The positive predictive value is only 20–40%, meaning 60–80% of women with positive fFN will NOT deliver within 7 days. **Clinical Pearl:** The strength of fFN testing lies in its **negative predictive value**. A negative test is highly reassuring and can reduce unnecessary interventions, hospitalization, and corticosteroid administration in low-risk patients. ### Interpretation Framework ```mermaid flowchart TD A[Symptoms of preterm labor<br/>22-34 weeks]:::outcome --> B[fFN test]:::action B --> C{fFN result}:::decision C -->|Negative| D[NPV 90-99%<br/>Low risk of delivery<br/>within 7 days]:::outcome C -->|Positive| E[PPV 20-40%<br/>Intermediate risk<br/>Consider interventions]:::outcome D --> F[Reassurance, outpatient<br/>management, avoid steroids]:::action E --> G[Corticosteroids,<br/>Tocolytics,<br/>Transfer to tertiary center]:::action ``` ### Correct Statements About fFN **Statement 1 — Negative Predictive Value (CORRECT):** - A negative fFN test has NPV of 90–99% for delivery within 7 days - This is the most clinically useful application of fFN - Allows safe discharge and outpatient management in symptomatic women **Statement 3 — Optimal Gestational Age Window (CORRECT):** - fFN testing is most useful between 22 and 34 weeks - Before 22 weeks: high background positivity, low specificity - After 34 weeks: approaching term, less clinical utility - Peak utility is 24–34 weeks **Statement 4 — Biochemical Nature (CORRECT):** - fFN is a glycoprotein (also called oncofetal fibronectin) - Component of the extracellular matrix at the choriodecidual junction - Normally absent from cervicovaginal secretions after 20 weeks - Its presence indicates disruption of the maternal-fetal interface ### Why Statement 2 Is Incorrect **Warning:** Positive fFN does NOT indicate imminent delivery within 24 hours in all cases. The positive predictive value for delivery within 7 days is only 20–40%. Many women with positive fFN will continue pregnancy beyond 7 days and deliver at term. Clinicians must not over-interpret a positive result. **Clinical Pearl:** fFN is a risk stratification tool, not a diagnostic test for preterm labor. It helps identify which symptomatic women are at higher risk and which can be safely managed conservatively. ### Management Based on fFN Result | fFN Result | Clinical Action | |---|---| | **Negative** | Reassurance; discharge if no other indicators of preterm labor; avoid corticosteroids; outpatient follow-up | | **Positive** | Consider corticosteroids (if 24–34 weeks); tocolytics (if labor); transfer to tertiary center; close monitoring | **Mnemonic for fFN Utility — "NPV > PPV":** - **N** — Negative predictive value is excellent (90–99%) - **P** — Positive predictive value is poor (20–40%) - **V** — Value lies in reassurance when negative - **P** — Positive result requires further evaluation, not automatic delivery - **P** — Presence indicates interface disruption, not imminent delivery
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.